HOME PAGE | ACTIVITIES

 

Cost and registration  Cost and registration        Share on LinkedIn  Share on LinkedIn        

Friday, April 16, 2010  [+]
Program        

BIOPHARMACEUTICS

 

A PRIORITY SECTOR FOR QUÉBEC

The biopharmaceuticals industry is a key economic sector for the greater metropolitan region and for Québec as a whole. Its position as a leading player must be preserved to successfully stave off strong competition from foreign markets. The Board of Trade invites you to take part in a strategic forum that will allow you to:

 

  • Identify the challenges facing the biopharmaceuticals sector.
  • Discuss the necessary actions to be taken to maintain and develop this strategic sector
    of the Montréal economy.
  • Become aware of strong North American and global competition.
  • Recognize the importance of the means used to develop and attract new companies.

 

Join key decision-makers from the public and private spheres who will be in attendance to discuss the actions required in order to maintain and develop this strategic sector of Montréal’s economy.

INDUSTRY EXPERTS

Share the reflections of key experts in the Québec biopharmaceuticals milieu. Be at the forefront of the news concerning this industry’s latest developments and challenges.

 

THE QUEBEC-ONTARIO
BIOPHARMA CORRIDOR
Michel Audet
Former Minister of Economic Development and former Finance Minister
Government of Quebec

THE OPTIMUM USE OF MEDICATION

Yola Moride

Associate Professor

Université de Montréal

GIVING NEW MOMENTUM
TO RISK CAPITAL
Jacques Bernier
Manager

Teralys Capital Fund

 THE FUNDAMENTAL ROLE OF
UNIVERSITY RESEARCH
Vassilios Papadopoulos
Director of the Research Institute and Associate Executive Director for Research, McGill University Health Centre

DRUG DISCOVERY IN THE UNIVERSITY MILIEU: A NEW MODEL OF PARTNERSHIP WITH THE BIOPHARMACEUTICAL INDUSTRY

Michel Bouvier

Principal Researcher and Deputy Director, Institute for Research in Immunology and Cancer, Université de Montréal

 

ARE OUR BIOTECHS CONDEMNED TO BE VICTIMS OF FINANCIAL STRANGULATION?
Yves Rosconi
President and CEO, Theratechnologies, and Chairman of the Board, BioQuébec

A PORTRAIT OF THE GENERAL STATE
OF THE LIFE SCIENCES SECTOR
Daniel Denis
Partner, SECOR

INCREASINGLY FIERCE COMPETITION
Michelle Savoie
General Manager

Montréal InVivo
INNOVATIVE PARTNERS IN BIOPHARMACEUTICAL RESEARCH
Max Fehlmann
President and CEO, Québec Consortium for Drug Discovery

ACCESS TO QUEBEC: HOW TO DO BETTER

Russell Williams
President
Canada's Research-Based Pharmaceutical Companies (Rx&D)

 

 

CLINICAL RESEARCH: A WORLD OF OPPORTUNITIES TO SEIZE IN AN INDUSTRY WITHOUT BORDERS

Janice E. Parente

President and Managing Director, ethica Clinical Research

 
Take part in the discussion on major issues in the biopharmaceuticals sector
 
DATE AND LOCATION

Friday, April 16, 2010
from 7:30 a.m. to noon

Fairmont The Queen Elizabeth
900 René-Lévesque Blvd. W.
Tous azimuts Bonaventure 
Neighbourhood map Neighbourhood map		 COST

Until April 2, 2010:
Members: $350 *
Non-members: $450 *

 

After April 2, 2010:
Members: $450 *
Non-members: $550 *

* Taxes not included.
No registrations, cancellations or refunds 2 business days preceding the activity.

 REGISTRATION
INFORMATION
Jonathan Terninck
Project manager, VIP events
514 871-4000, ext. 4042
jterninck@ccmm.qc.ca
In collaboration with:
Affaires, Journal Les RobicSITQ